2023 list of global top 10 biotech and pharmaceutical companies based on net income
This statistic shows the 2023 ranking of the top 10 biotech and pharmaceutical companies worldwide, based on net income. U.S.-based company Pfizer was ranked first with a net income of some 31 billion U.S. dollars.
Biotech and pharmaceutical companies
Pfizer and Johnson & Johnson, both based in the United States, are among the world’s largest biotechnology and pharmaceutical companies based on their net incomes of approximately 31 billion U.S. dollars and 18 billion U.S. dollars, respectively, as of 2023. Pfizer generated some 81 billion U.S. dollars of revenue in 2021. Johnson & Johnson had a market capitalization of some 425 billion U.S. dollars as of 2022. Roche, a Switzerland-based company, is considered the leader by biotech drugs revenue, generating 41 billion U.S. dollars in 2019, and is expected to reach nearly 49 billion U.S. dollars in biotech prescription drug revenue in 2026.
Lyrica was one of Pfizer’s most successful products. It is an anticonvulsant for neuropathic pain and is also used as therapy for partial seizures. In the EU and in Russia, Lyrica has also been approved to treat general anxiety disorder. In 2017, this prescription medication generated some five billion U.S. dollars in revenue. The United States and France boast the largest number of biotechnology companies in the world by a significant margin. As of 2020, there were 1,500 dedicated biotechnology companies in the United States and 1,510 companies in France.
Biotech and pharmaceutical companies
Pfizer and Johnson & Johnson, both based in the United States, are among the world’s largest biotechnology and pharmaceutical companies based on their net incomes of approximately 31 billion U.S. dollars and 18 billion U.S. dollars, respectively, as of 2023. Pfizer generated some 81 billion U.S. dollars of revenue in 2021. Johnson & Johnson had a market capitalization of some 425 billion U.S. dollars as of 2022. Roche, a Switzerland-based company, is considered the leader by biotech drugs revenue, generating 41 billion U.S. dollars in 2019, and is expected to reach nearly 49 billion U.S. dollars in biotech prescription drug revenue in 2026.
Lyrica was one of Pfizer’s most successful products. It is an anticonvulsant for neuropathic pain and is also used as therapy for partial seizures. In the EU and in Russia, Lyrica has also been approved to treat general anxiety disorder. In 2017, this prescription medication generated some five billion U.S. dollars in revenue. The United States and France boast the largest number of biotechnology companies in the world by a significant margin. As of 2020, there were 1,500 dedicated biotechnology companies in the United States and 1,510 companies in France.
